1-D-228

N/A

Report date: 2025/02/25 15:13:07
NME

Base Information

Drug Name1-D-228
Drug Alias Name1D2281-D-228
ClassificationSmall molecules
Mechanisms of ActionHepatocyte growth factor receptor inhibitorsNeurotrophic tyrosine kinase receptor type 2 inhibitors
TargetsHepatocyte growth factor receptorNeurotrophic tyrosine kinase receptor type 2
Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesGuangdong Lewwin Pharmaceutical Research Institute Co LtdGuangzhou Zhongkelian Pharmaceutical Research Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesGuangzhou Zhongkelian Pharmaceutical Research Co LtdGuangdong Lewwin Pharmaceutical Research Institute Co Ltd
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell Lung
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A